Singapore markets closed

Straits Times Index
3,300.04
-3.15(-0.10%)
S&P 500
5,180.74
+52.95(+1.03%)
Dow
38,852.27
+176.59(+0.46%)
Nasdaq
16,349.25
+192.92(+1.19%)
Bitcoin USD
63,852.79
-1,070.69(-1.65%)
CMC Crypto 200
1,329.62
-35.51(-2.60%)

Nevro Corp. (NVRO)

NYSE - NYSE Delayed price. Currency in USD

Add to watchlist

11.15

-0.14

(-1.24%)

At close: 04:00PM EDT

11.15

0.00

(0.00%)

After hours:

04:37PM EDT

Loading interactive chart…

Zacks
Will These 5 Medical Device Stocks Beat This Earnings Season?
Medical Device companies' quarterly results are likely to reflect strength in customer demand. Let's see how INSP, MCK, FMS, NVRO and INGN are placed ahead of their earnings releases.
PR Newswire
Nevro to Report First-Quarter 2024 Financial Results and Host Earnings Conference Call on May 7, 2024
Nevro Corp. (NYSE: NVRO), a global medical device company delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced that it will release its financial results for the first quarter of 2024 after the market closes on Tuesday, May 7, 2024. The company will also host a conference call beginning at 1:30 p.m. PDT (4:30 p.m. EDT) to discuss its financial results.
Zacks
Abbott (ABT) Expands in Canada With First Eterna SCS Use
Abbott's (ABT) Eterna SCS system reduces pain without causing discomfort. It leverages the BurstDR stimulation technology.